TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/03/2026
Voltar para busca
Dado oficial do USPTO
EXOTAC
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
18/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
03/11/2021
Data de registro
30/07/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/07/2024
Última transação
18/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Daejeon, KR
Examinador
DWYER, JOHN D
Unidade examinadora
M70
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
ILIAS Biologics Inc.
Representantes
Janice Housey Litmus Law PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Biological preparationsother than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; biological preparation for use in the manufacture of pharmaceuticals; biological preparations for use in experiments containing exosomes carrying the desired proteinother than for medical or veterinary use; biochemical preparations for gene recombination for scientific or laboratory purposes; biological tissue culturesother than for medical or veterinary purposes; cells for scientific or laboratory purposes; biological preparations for scientific or laboratory purposes other than for medical or veterinary use; diagnostic reagents for scientific or research use; diagnostic reagents for use in biological or genetic engineering for scientific or research use and medical laboratory use; reagents for scientific or medical research use; biological preparations for use in biotechnology industry and scienceother than for medical purpose; cell growth media for growing cells for use in scientific research; biochemicals for in vitro and in vivo scientific use; reagents for medical research; biological preparation containingexosomes for use in manufacture of cosmetics; protein for use in the manufacture of cosmetics; chemical preparations for use in the manufacture of cosmetics; chemical additives for use in the manufacture of cosmetics; proteins for the food industry
Classe 5
Biological preparations for medical or veterinary purposes for the treatment of cancermetabolic diseasesinflammatory diseasesgenetic diseasesinfectious diseasescardiovascular diseasesrespiratory diseasesneurological diseasesauto-immune diseasesfibrosis diseasesallergiesskin diseasesendocrine diseasesgastrointestinal diseaseshematologic diseasesdiseases and disorders of the immune systemophthalmic diseaseskidney diseasesurinary diseases; biochemical preparations for medical or veterinary purposes for the treatment of cancermetabolic diseasesinflammatory diseasesgenetic diseasesinfectious diseasescardiovascular diseasesrespiratory diseasesneurological diseasesauto-immune diseasesfibrosis diseasesallergiesskin diseasesendocrine diseasesgastrointestinal diseaseshematologic diseasesdiseases and disorders of the immune systemophthalmic diseaseskidney diseasesurinary diseases; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceuticals featuring drug delivery systempharmaceutical preparations for the treatment of cancermetabolic diseasesinflammatory diseasesgenetic diseasesinfectious diseasescardiovascular diseasesrespiratory diseasesneurological diseasesauto-immune diseasesfibrosis diseasesallergiesskin diseasesendocrine diseasesgastrointestinal diseaseshematologic diseasesdiseases and disorders of the immune systemophthalmic diseaseskidney diseasesurinary diseases; preparations for intracellular drug deliverydrug delivery agents in the form of capsulestabletspillspowdersliquidssuspensionsinjectionscreamsemulsionsgelslinimentslotionsointmentspathessolutionssyrupsaerosolsgranulesimplantsinhalantspellets that facilitate the delivery of pharmaceutical preparations; pharmaceuticals for the treatment of immune system disease; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of cellular diseases; chemico-pharmaceutical preparations for the treatment of cancermetabolic diseasesinflammatory diseasesgenetic diseasesinfectious diseasescardiovascular diseasesrespiratory diseasesneurological diseasesauto-immune diseasesfibrosis diseasesallergiesskin diseasesendocrine diseasesgastrointestinal diseaseshematologic diseasesdiseases and disorders of the immune systemophthalmic diseaseskidney diseasesurinary diseases; protein preparationsprotein supplements; biotechnological preparations for medical purposes for treatment of cancermetabolic diseasesinflammatory diseasesgenetic diseasesinfectious diseasescardiovascular diseasesrespiratory diseasesneurological diseasesauto-immune diseasesfibrosis diseasesallergiesskin diseasesendocrine diseasesgastrointestinal diseaseshematologic diseasesdiseases and disorders of the immune systemophthalmic diseaseskidney diseasesurinary diseases; reagents for medical use; pharmaceuticals for human purposes for the treatment of cancermetabolic diseasesinflammatory diseasesgenetic diseasesinfectious diseasescardiovascular diseasesrespiratory diseasesneurological diseasesauto-immune diseasesfibrosis diseasesallergiesskin diseasesendocrine diseasesgastrointestinal diseaseshematologic diseasesdiseases and disorders of the immune systemophthalmic diseaseskidney diseasesurinary diseases; biochemical pharmaceuticals for the treatment of cancermetabolic diseasesinflammatory diseasesgenetic diseasesinfectious diseasescardiovascular diseasesrespiratory diseasesneurological diseasesauto-immune diseasesfibrosis diseasesallergiesskin diseasesendocrine diseasesgastrointestinal diseaseshematologic diseasesdiseases and disorders of the immune systemophthalmic diseaseskidney diseasesurinary diseases; biological tissue cultures for medical purposes; diagnostic reagents for medical use; pharmaceuticals for the treatment of cancermetabolic diseasesinflammatory diseasesgenetic diseasesinfectious diseasescardiovascular diseasesrespiratory diseasesneurological diseasesauto-immune diseasesfibrosis diseasesallergiesskin diseasesendocrine diseasesgastrointestinal diseaseshematologic diseasesdiseases and disorders of the immune systemophthalmic diseaseskidney diseasesurinary diseases
Classe 42
Research and development of technology for biotechnology; development of pharmaceutical preparations and medicines; development of cell therapy products; research and development of new pharmaceuticals; medical research and product development services; research and development of vaccines and medicines; product development in the field of biologics; research of biologicsscientific study and research in the field of biologics; laboratory research in the field of biology; industrial research in the field of biomedical engineering; technological research in the field of cell biology; scientific research in the field of pharmaceuticals; biotechnology research; biological research services; research for medical products; research in the field of chemistry; drug discovery services; biomedical research services; pharmaceutical drug development services
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
16/03/2026
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
16/03/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/03/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/03/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
16/03/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
16/03/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
30/07/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
30/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/05/2024
PUBO
PUBLISHED FOR OPPOSITION
14/05/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/04/2024
ALIE
ASSIGNED TO LIE
09/04/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
18/11/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
11/09/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
11/09/2023
CNSI
SUSPENSION INQUIRY WRITTEN
11/09/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
14/03/2023
GNSL
LETTER OF SUSPENSION E-MAILED
14/03/2023
CNSL
SUSPENSION LETTER WRITTEN
14/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/02/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/02/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/02/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
21/08/2022
GNRT
NON-FINAL ACTION E-MAILED
21/08/2022
CNRT
NON-FINAL ACTION WRITTEN
21/08/2022
DOCK
ASSIGNED TO EXAMINER
13/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/11/2021
NWAP
NEW APPLICATION ENTERED
06/11/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EXOTAC ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.